Women's Peptide Therapy: An Underserved Frontier

Search “peptide therapy” and almost everything that shows up is written for men — addressing testosterone-adjacent concerns, men's body composition, men's recovery patterns. The compounds work for women too. The mechanisms are the same. Sometimes the response is actually better in women than in men. This page is the version of the peptide- therapy conversation that the men's-health-marketing machine hasn't bothered to write.

Why the women's side gets overlooked

Three reasons:

• Men's clinics drive most peptide-therapy marketing. They sell to their existing patient base, so the content is built around male physiology, male goals, and male body composition concerns
• Clinical trial data is testosterone-anchored. A lot of peptide research piggybacked on TRT studies, which skewed male
• Women have more “built-in” estrogen-driven recovery during reproductive years, so the window where peptide therapy becomes additive is later — often peri- and post-menopause

That doesn't mean the compounds don't work for women. It means the conversation hasn't been written for women.

Peptides that fit women particularly well

Sermorelin and CJC-1295 / Ipamorelin

GHRH-class peptides work equivalently well in women as in men — and often produce more visible body-composition results in women because the baseline GH/IGF-1 axis declines more sharply in women through the perimenopausal transition. Women often report particularly strong sleep-architecture improvements, better recovery from exercise, and reduced abdominal fat accumulation.

BPC-157

Tissue-repair peptide doesn't care about sex. Women with chronic soft-tissue injuries, recurrent tendinopathy, or post-surgical recovery benefit equivalently. The most common indications we see in women: post-orthopedic-surgery recovery, chronic gut-barrier issues (often connected to autoimmune conditions like Hashimoto's), and rehab from connective- tissue injuries.

GHK-Cu

Copper peptide with significant dermatological use case in women — skin remodeling, collagen support, hair restoration adjunct. Often a better fit for women than men because the aesthetic indications overlap with what women are actually asking for. Routinely combined with women's HRT for full-spectrum “feel and look like myself again” protocols.

PT-141 (Bremelanotide)

The only peptide with FDA approval specifically for women. Approved for hypoactive sexual desire disorder in premenopausal women. On-demand injectable; acts on melanocortin receptors in the central nervous system, which is a different mechanism from anything else available for sexual wellness.

Combined hormone + peptide protocols

Most women in our practice who want peptide therapy also have a perimenopause or menopause hormone picture worth optimizing. The most common protocol pairing:

• Bioidentical estradiol (transdermal patch or cream) + progesterone (oral or topical) for the hormone foundation
• Sermorelin or CJC/Ipa for sleep, recovery, body composition
• Possibly NAD+ or GHK-Cu layered in based on goals

The hormone work is usually the larger lever. Peptides are additive — they don't replace the hormone foundation, but they meaningfully enhance the effects when the hormone picture is correct.

What women should typically skip

• High-dose testosterone protocols. Some clinics push testosterone hard for women. Free testosterone matters and should be on labs, but supraphysiologic dosing isn't the answer for most women
• Tesamorelin specifically for weight loss. The visceral-fat indication is strongest in male HIV lipodystrophy populations. For most women, GLP-1 or basic GHRH peptides are more direct

How Vektor approaches women's peptide therapy

Every women's protocol starts with a full hormone panel (estradiol, progesterone, FSH, LH, total + free testosterone, SHBG, thyroid panel, DHEA-S). Peptide selection follows the hormone picture, not the other way around. Membership ($149/mo founding) covers the physician relationship and labs; each peptide protocol is priced à la carte through our 503A pharmacy partner.